Is the Pharmaceutical Industry Improving with Regard to Access to Essential Medicines?
(2014; 2 pages)

Resumen

Despite progress in many countries, about a third of the world’s population does not have regular access to essential medicines. The responsibility to resolve this problem lies with many, including the pharmaceutical industry. Since 2008, the Access to Medicine Index (the Index) has ranked the 20 largest research-based pharmaceutical companies according to their efforts in making relevant products more available, affordable, and accessible in developing countries.

The 2012 Index ranking is based on companies’ commitments and actions to provide medicines, vaccines, and diagnostic tests in 103 low-income and middle-income countries, focusing on 33 high-burden communicable, non-communicable, and neglected tropical diseases, as well as a range of maternal and neonatal disorders. Information received from companies

 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 7 octubre 2014